Cardiac troponin: A critical review of the case for point-of-care testing in the ED

American Journal of Emergency Medicine

Volumn 30, Issue 8, 2012, Pages 1639-1649

  Bingisser, Roland ^a   Cairns, Charles ^b   Christ, Michael ^c   Hausfater, Pierre ^d   Lindahl, Bertil ^e   Mair, Johannes ^f   Panteghini, Mauro ^g   Price, Christopher ^h   Venge, Per ⁱ  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Department of Neurology   (Germany)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; HUMAN; PATIENT CARE; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW;

EID: 84869420653     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2012.03.004     Document Type: Review

References (58)

1. Goodacre S, Cross E, Arnold J, et al. The health care burden of acute chest pain. Heart 2005;91:229-30.
2. Lindsell CJ, Anantharaman V, Diercks D, et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 2006;48:666-77.
3. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
4. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-204.
5. Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51. (Pubitemid 46580222)
6. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74. (Pubitemid 46580223)
7. Amsterdam EA, Kirk JD, Bluemke DA, et al. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation 2010;122:1756-76.
8. Novis DA, Jones BA, Dale JC, et al. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med 2004;128:158-64. (Pubitemid 38155661)
9. Hwang U, Baumlin K, Berman J, et al. Emergency department patient volume and troponin laboratory turnaround time. Acad Emerg Med 2010;17:501-7.
10. Storrow AB, Apple FS, Wu AH, et al. Use of cardiac biomarkers for acute coronary syndromes. In: Nichols JH, editor. National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines; evidence-based practice for point-of-care testing. Washington, DC: AACC Press; 2006. p. 13-20. http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCTLMPG.pdf#page=1. (Accessed February 5, 2012).
11. Storrow AB, Lyon JA, Porter MW, et al. A systematic review of emergency department point-of-care cardiac markers and efficiency measures. Point Care 2009;8:121-5.
12. Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008;118:2200-6.
13. Steurer J, Held U, Schmid D, et al. Clinical value of diagnostic instruments for ruling out acute coronary syndrome in patients with chest pain: a systematic review. Emerg Med J 2010;27:896-902.
14. Body R, Carley S, Wibberley C, et al. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation 2010;81:281-6.
15. Hess EP, Perry JJ, Calder LA, et al. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome. Acad Emerg Med 2010;17:368-75.
16. Hess EP, Agarwal D, Chandra S, et al. Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis. CMAJ 2010;182:1039-44.
17. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-12. (Pubitemid 33098158)
18. Zahid M, Good CB, Singla I, et al. Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome. Am J Cardiol 2009;104:164-8.
19. Christ M, Bertsch T, Popp S, et al. High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department. Clin Chem Lab Med 2011 (6 September, epub ahead of print).
20. Hamm CW, Bassand JP, Agewall S, et al, The Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32: 2999-3054.
21. Yan AT, Yan RT, Huynh T, et al. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. Arch Intern Med 2009;169:372-8.
22. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
23. Scharnhorst V, Krasznai K, van't Veer M, et al. Rapid detection of myocardial infarction with a sensitive troponin test. Am J Clin Pathol 2011;135:424-8.
24. Collinson PO. Cardiac biomarkers by point-of-care testing. In: Morrow DA, editor. Cardiovascular biomarkers. Pathophysiology and disease management. Totowa, NJ: Humana Press; 2006. p. 559-74.
25. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent STsegment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
26. Than M, Cullen L, Reid CM, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 2011;377:1077-84.
27. Christenson RH, Azzazy HM. Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms. Clin Biochem 2009;42:150-7.
28. International Federation of Clinical Chemistry and Laboratory Medicine. Troponin assay analytical characteristics. http://www.ifcc.org/PDF/ ScientificActivities/IFCC-Troponin-Table-vDec-2010-FINAL-ug-L-28Jan11.pdf. Accessed February 5, 2012.
29. Dittmer WU, Evers TH, Hardeman WM, et al. Rapid, high sensitivity, point-of-care test for cardiac troponin based on optomagnetic biosensor. Clin Chim Acta 2010;411:868-73.
30. Bock JL, Singer AJ, Thode Jr HC. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I. Am J Clin Pathol 2008;130:132-5.
31. Gruson D, Thys F, Ketelslegers JM, et al. Multimarker panel in patients admitted to emergency department: a comparison with reference methods. Clin Biochem 2009;42:185-8.
32. Venge P, Ohberg C, Flodin M. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. Am Heart J 2010;160:835-41.
33. Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011;40:139-46.
34. Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 2001;88:611-7.
35. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001; 104:1483-8. (Pubitemid 32917339)
36. Rathore S, Knowles P, Mann AP, et al. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain? Eur J Intern Med 2008;19: 537-40.
37. Collinson PO, John C, Lynch S, et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem 2004;41:397-404. (Pubitemid 39279926)
38. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med 2008;15: 216-24.
39. Ryan RJ, Lindsell CJ, Hollander JE, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. Ann Emerg Med 2009;53:321-8.
40. Goodacre SW, Bradburn M, Cross E, et al. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011;97: 190-6.
41. Goodacre S, Bradburn M, Fitzgerald P, et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011;15:1-108.
42. Loten C, Attia J, Hullick C, et al. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trial. Emerg Med J 2010;27: 194-8.
43. Takakuwa KM, Ou FS, Peterson ED, et al. The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE. Clin Cardiol 2009;32:498-505.
44. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-6.
45. Herring A, Wilper A, Himmelstein DU, et al. Increasing length of stay among adult visits to U.S. Emergency departments, 2001-2005. Acad Emerg Med 2009;16:609-16.
46. Price CP, StJohn A, Christenson RH. Testing at the point of care: errors of omission in a care pathway context. Point Care 2011;10: 182-5.
47. Bradburn M, Goodacre SW, Fitzgerald P, et al. Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers). Emerg Med J 2011;29:233-8.
48. Gill D, Galvin S, Ponsford M, et al. Laboratory sample turnaround times: do they cause delays in the ED? J Eval Clin Pract 2012;18: 121-7.
49. Fitzgerald P, Goodacre SW, Cross E, et al. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the Randomized Assessment of Treatment Using Panel Assay of Cardiac Markers (RATPAC) trial. Acad Emerg Med 2011;18:488-95.
50. Apple FS, Chung AY, Kogut ME. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 2006;370:191-5. (Pubitemid 44080188)
51. Ordóñez-Llanos J, Santaló-Bel M, Mercé- Muntañola J, et al. Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department. Clin Chim Acta 2006;365:93-7. (Pubitemid 43196421)
52. Singer AJ, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med 2005;45:587-91. (Pubitemid 40812890)
53. Price CP, St John A, Kricka LJ. Point of care testing in context: challenges of translating innovation into benefit. In: Price CP, St John A, Kricka L, editors. Point-of-care testing - needs, opportunity, and innovation. 3rd ed. Washington, DC: AACC Press; 2010. p. 571-81.
54. Storrow AB, Zhou C, Gaddis G, et al. Decreasing lab turnaround time improves emergency department throughput and decreases emergency medical services diversion: a simulation model. Acad Emerg Med 2008;15:1130-5.
55. McLachlan A, Wells S, Furness S. Equity of access to CVD risk management using electronic clinical decision support in the coronary care unit. Eur J Cardiovasc Nurs 2010;9:233-7.
56. Riggio JM, Sorokin R, Moxey ED, et al. Effectiveness of a clinicaldecision-support system in improving compliance with cardiac-care quality measures and supporting resident training. Acad Med 2009;84: 1719-26.
57. FitzGibbon F, Huckle B, Meenan BJ. Barriers affecting the adoption of point-of-care technologies used in chest pain diagnosis within the UK National Health Service. Part 1: user issues. Point Care 2010;9: 70-9.
58. FitzGibbon F, Huckle B, Meenan BJ. Barriers affecting the adoption of point-of-care technologies used in chest pain diagnosis within the UK National Health Service. Part 2: manufacturer pricing and reimbursement policy issues. Point Care 2010;9:80-90